Issues to Be Addressed and Hopefully Resolved in the Carotid Revascularization Endarterectomy Versus Stenting Trial 2

Area of Science:

• Neurology
• Vascular Surgery
• Cardiology

Background:

• Carotid endarterectomy (CEA) plus best medical treatment (BMT) has historically shown superiority over BMT alone for asymptomatic carotid stenosis.
• Significant advancements in BMT for stroke prevention have occurred since initial trials.
• Carotid artery stenting (CAS) has emerged as a viable alternative intervention over the past two decades.

Purpose of the Study:

• To compare the efficacy of current BMT alone versus CEA plus BMT and CAS plus BMT.
• To determine the optimal stroke prevention strategy for patients with asymptomatic carotid stenosis.
• To highlight the objectives and research questions of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST) 2.

Main Methods:

• The article discusses the design and rationale of the CREST-2 trial.
• CREST-2 is a randomized controlled trial comparing CEA and CAS in conjunction with BMT against BMT alone.
• Focus on patient selection criteria and outcome measures for stroke prevention.

Main Results:

• The article anticipates results from CREST-2 regarding stroke prevention rates.
• It aims to provide evidence-based comparisons between CEA, CAS, and medical management.
• Expected findings will guide clinical decision-making for asymptomatic carotid stenosis.

Conclusions:

• The study aims to update evidence on the best management strategy for asymptomatic carotid stenosis.
• Findings will clarify the role of CEA and CAS in the context of modern BMT.
• Optimal stroke prevention will be addressed by comparing revascularization techniques with medical therapy.